MCID: DBT002
MIFTS: 42

Diabetic Autonomic Neuropathy malady

Category: Neuronal diseases

Aliases & Classifications for Diabetic Autonomic Neuropathy

About this section

Aliases & Descriptions for Diabetic Autonomic Neuropathy:

Name: Diabetic Autonomic Neuropathy 11 49 13 67
 
Diabetic Neuropathies 38 67

Classifications:



External Ids:

Disease Ontology11 DOID:11503
MeSH38 D003929
SNOMED-CT61 50620007
NCIt44 C27068

Summaries for Diabetic Autonomic Neuropathy

About this section
MalaCards based summary: Diabetic Autonomic Neuropathy, also known as diabetic neuropathies, is related to diabetic neuropathy and microvascular complications of diabetes 1, and has symptoms including sciatica and neuralgia. An important gene associated with Diabetic Autonomic Neuropathy is AKR1B1 (Aldo-Keto Reductase Family 1 Member B), and among its related pathways are Neurotrophic factor-mediated Trk receptor signaling and p75(NTR)-mediated signaling. The drugs capsaicin pwdr and mexiletine hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and skin, and related mouse phenotypes are muscle and normal.

Related Diseases for Diabetic Autonomic Neuropathy

About this section

Diseases related to Diabetic Autonomic Neuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
idRelated DiseaseScoreTop Affiliating Genes
1diabetic neuropathy12.4
2microvascular complications of diabetes 111.4
3autonomic neuropathy10.9
4neuropathy10.9
5postpartum depression10.3EPO, INS
6benign eccrine breast spiradenoma10.3INS, NTF3
7glucosidase acid-1,4-alpha deficiency10.3EPO, INS
8agammaglobulinemia 610.3AKR1B1, INS
9conjunctival vascular disease10.3EPO, INS
10postural hypotension10.2
11opportunistic mycosis10.1AKR1B1, INS
12femoral neuropathy10.1AKR1B1, INS
13pancreatitis10.1
14hypoglycemia10.1
15breast mucoepidermoid carcinoma10.0EPO, INS
16repetitive motion disorders9.9DBH, INS
17constrictive pericarditis9.9DBH, INS
18iritis9.9
19sudden cardiac death9.9
20thymus lymphoma9.9NGF, NTF3
21chronic myelomonocytic leukemia9.8EPO, INS
22maternal uniparental disomy of chromosome 139.8DBH, INS
23myocardial infarction9.8
24pheochromocytoma9.7
25neuroblastoma9.7
26obesity9.7
27insulin-like growth factor i9.7
28reflex sympathetic dystrophy9.7
29acute myocardial infarction9.7
30artery disease9.7
31peripheral artery disease9.7
32atrial fibrillation9.7
33esophagitis9.7
34vascular disease9.7
35gastric dilatation9.7
36cerebritis9.7
37cardiomyopathy9.7
38autonomic dysfunction9.7
39dysautonomia9.7
40hypoxia9.7
41c5 deficiency9.7DBH, NGF
42rumination disorder9.5AKR1B1, EPO, INS, NGF
43parkinson disease, late-onset9.2DBH, NGF, NTF3
44diffuse large b-cell lymphoma9.2AKR1B1, EPO, INS, NGF, NTF3
45suppurative otitis media8.1AKR1B1, AOC1, DBH, EPO, INS, NTF3

Graphical network of the top 20 diseases related to Diabetic Autonomic Neuropathy:



Diseases related to diabetic autonomic neuropathy

Symptoms for Diabetic Autonomic Neuropathy

About this section

UMLS symptoms related to Diabetic Autonomic Neuropathy:


sciatica, neuralgia

Drugs & Therapeutics for Diabetic Autonomic Neuropathy

About this section

Drugs for Diabetic Autonomic Neuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 167)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Nabiloneapproved, investigationalPhase 4, Phase 31851022-71-05284592
Synonyms:
Cesamet
Nabilon
 
Nabilona
Nabilone
Nabilonum
2
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3, Phase 2355148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
3
Lidocaineapproved, vet_approvedPhase 41226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
4
Gabapentinapproved, investigationalPhase 428960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
5
CilostazolapprovedPhase 410373963-72-12754
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
73963-72-1
89332-50-3
AC-4334
AC1L1EE2
BRD-K67017579-001-04-2
BRD-K67017579-001-05-9
BRD-K67017579-001-07-5
BRD-K67017579-001-13-3
BRN 3632107
BSPBio_002759
C 0737
C045645
C0737_SIGMA
C20H27N5O2
CHEBI:31401
CHEMBL799
CID2754
CL23867
CPD000058428
Cilostazol (JP15/USAN/INN)
Cilostazol [INN:JAN]
Cilostazole
Cilostazolum
Cilostazolum [INN-Latin]
D01896
DB01166
EU-0100218
HMS1922N15
HMS2093M14
KBio3_002259
KBioGR_001184
 
LS-142693
Lopac-C-0737
Lopac0_000218
MLS000028470
MLS000758281
MLS000759507
MLS001076067
MLS002153891
MolPort-001-758-007
NCGC00015207-01
NCGC00015207-02
NCGC00015207-06
NCGC00015207-10
NCGC00022153-02
NCGC00022153-04
NCGC00022153-05
NCGC00022153-06
NCGC00022153-07
OPC 13013
OPC 21
OPC-13013
OPC-21
Otsuka brand of cilostazol
Pletaal
Pletal
Pletal (TN)
Pletal, Cilostazol
S1294_Selleck
SAM001246734
SAM001247085
SMR000058428
SPBio_001256
SPECTRUM1505230
Spectrum2_001118
Spectrum3_001170
Spectrum4_000772
Spectrum5_001762
TL8005113
Tocris-1692
UNII-N7Z035406B
ZINC01552174
cilostazol
6
Bromocriptineapproved, investigationalPhase 43125614-03-331101
Synonyms:
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
2-bromo-α-ergocryptine
2-bromo-α-ergokryptin
2-bromo-α-ergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
AC-13601
AC1L1KXS
AC1Q2716
Alti-Bromocriptine
Apo-Bromocriptine
BIDD:GT0464
BPBio1_001131
BRD-K14496212-001-01-1
Bagren
Biomol-NT_000005
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
Bromocriptine (USAN/INN)
Bromocriptine Methanesulfonate
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
 
Bromocriptine methanesulfonate
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CB-154
CCRIS 3244
CHEBI:3181
CHEMBL493
CID31101
D03165
DB01200
EINECS 247-128-5
Ergocryptine, 2-bromo- (8CI)
Ergoset
LS-64540
Lopac0_000171
MolPort-002-512-064
NCGC00024584-04
NCI60_001365
NSC169774
PDSP2_001500
Parlodel
Parlodel Snaptabs
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SPBio_002101
UNII-3A64E3G5ZO
bromocriptine
nchembio873-comp18
7
DopamineapprovedPhase 4, Phase 2375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
8
Methylprednisoloneapproved, vet_approvedPhase 4115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
9
Prednisoloneapproved, vet_approvedPhase 4115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
10Respiratory System AgentsPhase 4, Phase 3, Phase 2, Phase 14818
11AnalgesicsPhase 4, Phase 3, Phase 211287
12Excitatory Amino AcidsPhase 4, Phase 31297
13Hormone AntagonistsPhase 4, Phase 3, Phase 212778
14AnestheticsPhase 4, Phase 3, Phase 29001
15Anti-Anxiety AgentsPhase 4, Phase 3, Phase 21816
16AnticonvulsantsPhase 4, Phase 3, Phase 22620
17Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
18HormonesPhase 4, Phase 3, Phase 213979
19Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 212767
20Gastrointestinal AgentsPhase 4, Phase 3, Phase 28109
21Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 19774
22AntiemeticsPhase 4, Phase 3, Phase 23888
23Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
24Psychotropic DrugsPhase 4, Phase 3, Phase 26279
25Fibrinolytic AgentsPhase 4, Phase 12317
26Central Nervous System DepressantsPhase 4, Phase 3, Phase 212806
27Excitatory Amino Acid AntagonistsPhase 4, Phase 31282
28Tranquilizing AgentsPhase 4, Phase 3, Phase 24164
29GABA AgentsPhase 41622
30Anti-Inflammatory AgentsPhase 4, Phase 310355
31Sodium Channel BlockersPhase 41515
32
gamma-Aminobutyric AcidPhase 423056-12-2119
Synonyms:
3-Carboxypropylamine
4-Aminobutanoate
4-Aminobutanoic acid
4-Aminobutyrate
4-Aminobutyric acid
Aminalon
GABA
Gaballon
Gamarex
Gammalon
Gammalone
Gammar
Gammasol
 
Mielogen
Mielomade
Omega-Aminobutyrate
Omega-Aminobutyric acid
Piperidate
Piperidic acid
Piperidinate
Piperidinic acid
gamma Aminobutyrate
gamma Aminobutyric acid
gamma-Aminobutyrate
gamma-Aminobutyric acid
w-Aminobutyrate
w-Aminobutyric acid
33Diuretics, Potassium SparingPhase 41827
34Calcium, DietaryPhase 4, Phase 3, Phase 25525
35Phosphodiesterase InhibitorsPhase 4, Phase 21254
36Phosphodiesterase 3 InhibitorsPhase 4131
37Bronchodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12856
38Neuroprotective AgentsPhase 41672
39Platelet Aggregation InhibitorsPhase 42419
40Protective AgentsPhase 4, Phase 3, Phase 2, Phase 17190
41Antimanic AgentsPhase 4790
42Antiparkinson AgentsPhase 41527
43calcium channel blockersPhase 4, Phase 3, Phase 21940
44Anti-Arrhythmia AgentsPhase 42969
45Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 13438
46Anesthetics, LocalPhase 4, Phase 23272
47Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 2, Phase 13369
48Dopamine AgentsPhase 4, Phase 23759
49Dopamine agonistsPhase 4618
50Prednisolone acetatePhase 41153

Interventional clinical trials:

(show top 50)    (show all 75)
idNameStatusNCT IDPhase
1Inspiratory Muscle Training in Patients With Autonomic NeuropathicUnknown statusNCT00752440Phase 4
2Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral NeuropathyUnknown statusNCT00123136Phase 4
3Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes MellitusCompletedNCT03031834Phase 4
4Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled StudyCompletedNCT00466778Phase 4
5A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic NeuropathyCompletedNCT00573261Phase 4
6Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral NeuropathyCompletedNCT00380913Phase 4
7Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the PhilippinesCompletedNCT01076478Phase 4
8A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
9Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes SubjectsRecruitingNCT02682901Phase 4
10Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye DiseaseNot yet recruitingNCT02339142Phase 4
11Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic PainUnknown statusNCT01035281Phase 3
12Diabetic Neuropathy Topical TreatmentUnknown statusNCT00661063Phase 3
13An Intervention Trial for Cardiac Neuropathy in Type 1 DiabetesCompletedNCT00116207Phase 3
14Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)CompletedNCT00594152Phase 3
15Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.CompletedNCT00422955Phase 3
16Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)CompletedNCT01474772Phase 3
17Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another PainCompletedNCT01455415Phase 3
18Safety and Efficacy Study of Fx-1006A in Patients With Familial AmyloidosisCompletedNCT00409175Phase 2, Phase 3
19Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHONCompletedNCT00428727Phase 3
20The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)Enrolling by invitationNCT02510261Phase 3
21Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC IUnknown statusNCT02307526Phase 2
22Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) TherapyCompletedNCT01452113Phase 2
23Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral NeuropathyCompletedNCT00760955Phase 2
24A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainCompletedNCT01345045Phase 2
25Effects of Reiki on Painful Neuropathy and Cardiovascular Risk FactorsCompletedNCT00010751Phase 2
26Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic NeuropathyCompletedNCT00695565Phase 2
27Safety and Efficacy Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic NeuropathyCompletedNCT02068027Phase 2
28A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic NeuropathyCompletedNCT02355158Phase 2
29The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic NeuropathyCompletedNCT02643251Phase 2
30A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic NeuropathyCompletedNCT01633086Phase 2
31Effects of Moxaverine and Placebo on Ocular Blood FlowCompletedNCT00709423Phase 2
32Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot UlcersCompletedNCT01982565Phase 1, Phase 2
33Improving Autonomic Function and Balance in Diabetic NeuropathyRecruitingNCT01864460Phase 2
34Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic GastroparesisRecruitingNCT01557296Phase 2
35The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of DiabetesEnrolling by invitationNCT02915263Phase 2
36A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful NeuropathyTerminatedNCT00993018Phase 2
37Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot UlcersTerminatedNCT00316537Phase 1, Phase 2
38A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)WithdrawnNCT00837941Phase 2
39Effect of Local Application of Boron on Diabetic Foot UlcersUnknown statusNCT02087215Phase 1
40A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 DiabetesUnknown statusNCT01822431
41The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic NeuropathyUnknown statusNCT01706289
42Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes MellitusUnknown statusNCT01545024
43Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.Unknown statusNCT00155142
44The Relative Prevalence and Severity of Autonomic Nervous System DysfunctionCompletedNCT00919347
45Coronary Blood Flow Regulation During General AnesthesiaCompletedNCT00866801
46NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 DiabetesCompletedNCT01707979
47Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic PatientsCompletedNCT00953914
48Evaluation of Exenatide in Patients With Diabetic NeuropathyCompletedNCT00855439
49Diabetes Peripheral Neuropathy and Small-fibre Nerve Damage: A Comparative StudyCompletedNCT01160887
50Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 DiabetesCompletedNCT01171248

Search NIH Clinical Center for Diabetic Autonomic Neuropathy

Inferred drug relations via UMLS67/NDF-RT45:


Cochrane evidence based reviews: diabetic neuropathies

Genetic Tests for Diabetic Autonomic Neuropathy

About this section

Anatomical Context for Diabetic Autonomic Neuropathy

About this section

MalaCards organs/tissues related to Diabetic Autonomic Neuropathy:

35
Heart, Testes, Skin, Eye, Endothelial, Thyroid, Kidney

Animal Models for Diabetic Autonomic Neuropathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Diabetic Autonomic Neuropathy:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.0EPO, INS, NGF, NTF3, SYNM
2MP:00028738.6DBH, EPO, INS, NGF, NTF3
3MP:00053858.2AOC1, DBH, EPO, INS, NGF, NTF3
4MP:00053767.8AKR1B1, AOC1, DBH, EPO, INS, NGF
5MP:00053867.7AKR1B1, AOC1, DBH, INS, NGF, NTF3
6MP:00053917.4AKR1B1, AOC1, DBH, INS, NGF, NTF3

Publications for Diabetic Autonomic Neuropathy

About this section

Articles related to Diabetic Autonomic Neuropathy:

(show top 50)    (show all 287)
idTitleAuthorsYear
1
Diabetic autonomic neuropathy. (23393679)
2012
2
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. (21247746)
2011
3
Ergotamine use in severe diabetic autonomic neuropathy. (17227338)
2007
4
Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. (16389160)
2006
5
Ergotamine use in severe diabetic autonomic neuropathy. (16681568)
2006
6
Comparative neuropathology and diabetic autonomic neuropathy. (14578168)
2003
7
The effectiveness of treatments of diabetic autonomic neuropathy is not the same in autonomic nerves supplying different organs. (12502507)
2003
8
Diagnosis and management of diabetic autonomic neuropathy. (14606343)
2003
9
Decreased myocardial perfusion reserve in diabetic autonomic neuropathy. (12401723)
2002
10
Diabetic autonomic neuropathy causing gall bladder dysfunction. (11848318)
2001
11
Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. (9842405)
1998
12
Cholecystoparesis with diabetic autonomic neuropathy. (9313105)
1997
13
Early diagnosis of diabetic autonomic neuropathy: present and future approaches. (9112028)
1997
14
Diabetic autonomic neuropathy. (8536542)
1995
15
Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. (8438703)
1993
16
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. (8243821)
1993
17
Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy? (8404428)
1993
18
Early nocturnal blood pressure changes in diabetic autonomic neuropathy assessed by Fourier series. (8292880)
1993
19
The toxic effects of serum from patients with type 1 diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of diabetic autonomic neuropathy. (8306588)
1993
20
Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor. (8482988)
1993
21
A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy. (1688039)
1991
22
Diabetic autonomic neuropathy. (1862685)
1991
23
QT interval in diabetic autonomic neuropathy. (2147640)
1990
24
Airway responses to deep inspiration in diabetic autonomic neuropathy. (2135213)
1990
25
Gangliosides improve urinary bladder dysfunction in experimental diabetic autonomic neuropathy. (2097626)
1990
26
Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. (2353855)
1990
27
QT interval length and diabetic autonomic neuropathy. (2137059)
1990
28
Diabetic autonomic neuropathy and bladder function: pharmacological use of gangliosides and insulin. (2283091)
1990
29
Abnormal thermoregulation in diabetic autonomic neuropathy. (3384191)
1988
30
Improvement of postural hypotension and severe diabetic autonomic neuropathy during pregnancy. (3402296)
1988
31
Plasma dihydroxyphenylglycol (DHPG) as an index of diabetic autonomic neuropathy. (3229090)
1988
32
Cell-mediated immunity and symptomatic diabetic autonomic neuropathy. (2976645)
1988
33
Hypertension caused by clonidine in patients with diabetic autonomic neuropathy. (3608808)
1987
34
Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. (3614285)
1987
35
Loss of spontaneous variability of fingertip anastomotic blood flow in diabetic autonomic neuropathy. (3581682)
1987
36
Orthostatic hypotension due to diabetic autonomic neuropathy? Treatment with domperidone. (3800709)
1987
37
Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food. (3793851)
1987
38
Diabetic autonomic neuropathy. (3512955)
1986
39
Cardiac dysrhythmia in diabetic autonomic neuropathy. (4093409)
1985
40
Axonal dystrophy in experimental diabetic autonomic neuropathy. (7160544)
1982
41
Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. (6761211)
1982
42
Resting heart rate and diabetic autonomic neuropathy. (6954376)
1982
43
Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. (7018967)
1981
44
Dopamine beta-Hydroxylation in diabetes ane diabetic autonomic neuropathy. (7295304)
1981
45
Gastric emptying in diabetic autonomic neuropathy. (6769774)
1980
46
Tests of cardiovascular reflex function in diabetic autonomic neuropathy. (6929779)
1980
47
Diabetic autonomic neuropathy. (387501)
1979
48
Cardiorespiratory arrest and diabetic autonomic neuropathy. (74496)
1978
49
Defective innervation of heart in diabetic autonomic neuropathy. (1131653)
1975
50
Facial sweating after food: a new sign of diabetic autonomic neuropathy. (4144374)
1973

Variations for Diabetic Autonomic Neuropathy

About this section

Expression for genes affiliated with Diabetic Autonomic Neuropathy

About this section
Search GEO for disease gene expression data for Diabetic Autonomic Neuropathy.

Pathways for genes affiliated with Diabetic Autonomic Neuropathy

About this section

Pathways related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.4NGF, NTF3
2
Show member pathways
9.4NGF, NTF3
39.1EPO, INS, NGF

GO Terms for genes affiliated with Diabetic Autonomic Neuropathy

About this section

Cellular components related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1secretory granule lumenGO:00347749.7DBH, INS
2extracellular spaceGO:00056158.1AKR1B1, AOC1, DBH, EPO, INS
3extracellular regionGO:00055767.6DBH, EPO, INS, NGF, NTF3

Biological processes related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1activation of protein kinase B activityGO:003214810.2INS, NTF3
2acute-phase responseGO:000695310.1EPO, INS
3positive regulation of DNA replicationGO:00457409.9EPO, INS
4positive regulation of Ras protein signal transductionGO:00465799.5EPO, NGF
5regulation of neuron differentiationGO:00456649.4NGF, NTF3
6neuron projection morphogenesisGO:00488129.1NGF, NTF3
7cell-cell signalingGO:00072679.1INS, NGF, NTF3

Molecular functions related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1copper ion bindingGO:00055079.1AOC1, DBH

Sources for Diabetic Autonomic Neuropathy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet